Breast Cancer Home > Aredia and Breastfeeding
It is not known whether it is safe for breastfeeding women to take Aredia. Breastfeeding women should use caution while taking the drug because the medicine may potentially pass through breast milk. Researchers are not sure whether Aredia will affect growing bones of young infants. Therefore, if you are taking Aredia and breastfeeding (or thinking of breastfeeding), be sure to consult your healthcare provider.
Aredia® (pamidronate disodium) is a medication used in cancer patients and people with Paget's disease of bone. At this time, it is not known whether Aredia passes through breast milk in humans. The manufacturer of Aredia recommends that breastfeeding women use caution while taking the drug. This means that your healthcare provider should carefully weigh the benefits and risks of using Aredia in your particular situation and should monitor you and your child very closely if you take Aredia. If you are breastfeeding or are thinking about breastfeeding, you should talk with your healthcare provider before taking Aredia.
No studies have been conducted on whether Aredia passes through breast milk in women. Like all bisphosphonate medications, Aredia binds to bone and is released very slowly over time. It is not known how Aredia might affect growing bones (such as those of young infants). Also, it is not known how long to wait after taking Aredia before it is safe to breastfeed.
You should talk with your healthcare provider about Aredia and breastfeeding. Each woman's situation is different, and you and your healthcare provider understand your situation best. After considering what you want and expect, as well as your current health situation, you and your healthcare provider can make a shared decision about Aredia and breastfeeding that is right for you.